Yong Qing Luo
Chief Executive Officer presso EVEREST MEDICINES LIMITED
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Yong Qing Luo is currently the Chief Executive Officer & Executive Director at Everest Medicines Ltd.
and President & Executive Director at Brii Biosciences Ltd.
He is also the President & General Manager at Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
His former jobs include being an Associate Brand Director at Novartis AG, President, Executive Director & GM-Greater China at Brii Biosciences Ltd.
(China), Head-Great China Pharmaceutical Organization at Beijing Novartis Pharma Ltd., Vice President at Shanghai Roche Pharmaceuticals Ltd., and Global Vice President & General Manager-China at Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd.
Dr. Luo holds an MBA degree from China Europe International Business School and a doctorate degree from Xiangya School of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EVEREST MEDICINES LTD.
0.30% | 05/04/2024 | 980 474 ( 0.30% ) | 3 M $ | 31/03/2024 |
BRII BIOSCIENCES LIMITED
-.--% | 15/09/2022 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Yong Qing Luo
| Società | Posizione | Inizio |
|---|---|---|
| EVEREST MEDICINES LIMITED | Chief Executive Officer | 19/09/2022 |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | President | 17/09/2020 |
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | President | - |
Precedenti posizioni note di Yong Qing Luo
| Società | Posizione | Fine |
|---|---|---|
| BRII BIOSCIENCES LIMITED | President | 15/09/2022 |
| Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | Corporate Officer/Principal | 01/09/2020 |
Shanghai Roche Pharmaceuticals Ltd.
 Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The private company is based in Shenchang, China. | Corporate Officer/Principal | 01/08/2016 |
Beijing Novartis Pharma Ltd.
 Beijing Novartis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Beijing Novartis Pharma Ltd. is a pharmaceutical company. The private company is based in Beijing, China. Founded in 1987, it operates in the pharmaceutical industry. | Corporate Officer/Principal | 01/08/2012 |
| NOVARTIS AG | Corporate Officer/Principal | 01/06/2009 |
Formazione di Yong Qing Luo
| China Europe International Business School | Masters Business Admin |
| Xiangya School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| EVEREST MEDICINES LIMITED | Health Technology |
| BRII BIOSCIENCES LIMITED | Commercial Services |
| Aziende private | 5 |
|---|---|
Beijing Novartis Pharma Ltd.
Beijing Novartis Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Beijing Novartis Pharma Ltd. is a pharmaceutical company. The private company is based in Beijing, China. Founded in 1987, it operates in the pharmaceutical industry. | Health Technology |
Shanghai Roche Pharmaceuticals Ltd.
Shanghai Roche Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Part of Roche Holding AG, Shanghai Roche Pharmaceuticals Ltd. is a Chinese company that develops, manufactures, and distributes anti-cancer and virus drugs. The private company is based in Shenchang, China. | Health Technology |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | Health Technology |
| Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd. | |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | Health Technology |
- Borsa valori
- Insiders
- Yong Qing Luo
